MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Cardiovascular Systems Total Current Liabilities 2011-2026 | CSII
Annual Total Current Liabilities Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 40 M | 54.6 M | 44.5 M | 42.3 M | 37.5 M | 41 M | 35.5 M | 29.9 M | 29.7 M | 22.4 M | 17.9 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 54.6 M | 17.9 M | 35.9 M |
Total Current Liabilities of other stocks in the Medical devices industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Medtronic PLC
MDT
|
12.9 B | $ 86.75 | 0.2 % | $ 112 B |  USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
5.99 M | - | -0.97 % | $ 54.4 M | USA |
 |
InspireMD
NSPR
|
10.7 M | $ 1.75 | -2.23 % | $ 113 M |  Israel |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Orthofix Medical
OFIX
|
170 M | $ 11.8 | 0.68 % | $ 467 M |  Curacao |
 |
Inogen
INGN
|
63.5 M | $ 6.39 | 1.11 % | $ 170 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Insulet Corporation
PODD
|
680 M | $ 221.66 | -1.71 % | $ 15.6 B | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 33.48 | 2.67 % | $ 1.54 B | USA |
 |
CONMED Corporation
CNMD
|
315 M | $ 36.6 | 0.04 % | $ 1.14 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
AVITA Medical
RCEL
|
62.7 M | $ 3.96 | 3.13 % | $ 110 M |  Australia |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | Israel |
 |
NanoVibronix
NAOV
|
2.72 M | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
10.5 M | $ 24.42 | -1.13 % | $ 206 M | USA |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
MiMedx Group
MDXG
|
64.3 M | $ 4.18 | 1.33 % | $ 618 M | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.68 | -2.16 % | $ 37 M | USA |
 |
Aethlon Medical
AEMD
|
1.9 M | $ 2.29 | 5.79 % | $ 3.57 M | USA |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Sintx Technologies
SINT
|
3.73 M | $ 2.61 | 1.62 % | $ 7.24 M | USA |
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 11.61 | 1.13 % | $ 1.57 B | USA |
 |
Myomo
MYO
|
8.35 M | $ 0.71 | 2.39 % | $ 29.7 M | USA |
 |
Sensus Healthcare
SRTS
|
4.72 M | $ 4.21 | 6.31 % | $ 68.7 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
14 M | $ 2.37 | -1.29 % | $ 139 M | Israel |
 |
Penumbra
PEN
|
183 M | $ 335.58 | 0.4 % | $ 13.1 B | USA |
 |
Invacare Corporation
IVC
|
220 M | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 3.7 | -5.33 % | $ 138 M |  France |
 |
Quanterix Corporation
QTRX
|
74.8 M | $ 4.06 | 6.15 % | $ 173 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 16.14 | 1.45 % | $ 379 M | USA |
 |
Outset Medical
OM
|
37.6 M | $ 3.54 | 0.28 % | $ 53.8 K | USA |
 |
Inspire Medical Systems
INSP
|
96.1 M | $ 51.78 | -0.58 % | $ 1.52 B | USA |
 |
Pulmonx Corporation
LUNG
|
20.1 M | $ 1.33 | 1.15 % | $ 54.1 M | USA |
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | USA |